AGGARWAL GAURAV reported 1 transaction at UNICYCIVE THERAPEUTICS, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 10/10/2024ACC: 0001213900-24-086928
Director
Since Mar 2023
+5.50M
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
5.50M acquired · 2.69K disposed
Non-Derivative Transactions1
Common Stock
Indirect
Shares
+5.50M
Price / share
—
Trade value
—
% of position
123.0%
10/9/2024
4.47M→9.97M
Total
Net shares
+5.50M
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 10/9/2024 | C · Conversion | +5.50M | — | — | 123.0% | 4.47M | 9.97M |
| Total | +5.50M | $0.00 | ||||||
Derivative Transactions1
Series A-2 Prime Preferred Stock
Indirect
Converts to
Common Stock
5.50M shares
Shares
−2.69K
Strike price
0.49
Held after
3.89K
Exercisable
—
10/9/2024
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Series A-2 Prime Preferred Stock Indirect | Common Stock5.50M shares | 10/9/2024 | D · Disposition | −2.69K | 0.49 | — | 3.89K |